X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GSK Pharma Fact Sheet, GSK Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Fact Sheet   (GLXO)

Here is the latest financial fact sheet of GSK Pharma. For more details, see the GSK Pharma quarterly results and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

GSK PHARMA Price History

Price Rs 1,298.1
Mkt Cap Rs m 219,906
Vol '000 1.2
P/E X 53.9
P/CF X 56.6
EPS (TTM) Rs 24.1
% ch % -0.2
No. of shares m 169.41
% ch week % 0.2
% ch 1-mth % 0.6
% ch 12-mth % 10.0
52 week H/L Rs 1,812.0/1,135.9
(As on Apr 18, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GSK PHARMA Financials

No. of Mths
Year Ending
12
Dec-13
15
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
5-Yr Chart
Click to enlarge
GSK PHARMA EQUITY SHARE DATA
High Rs3,0023,5503,8503,8382,760 
Low Rs2,0052,3522,9662,6372,040 
Sales per share (Unadj.) Rs302.6396.5335.1343.4339.0 
Earnings per share (Unadj.) Rs56.955.744.439.841.4 
Diluted earnings per shareRs28.427.822.219.920.7 
Cash flow per share (Unadj.) Rs59.258.747.442.945.9 
Dividends per share (Unadj.) Rs50.0062.5050.0030.0035.00 
Adj. dividends per shareRs25.0031.2525.0015.0017.50 
Dividend yield (eoy) %2.02.11.50.91.5 
Book value per share (Unadj.) Rs234.9288.6257.8236.9242.9 
Adj. book value per shareRs117.5144.3128.9118.5121.4 
Shares outstanding (eoy) m84.7084.7084.7084.7084.70 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x8.37.410.29.47.1 
Avg P/E ratio x44.053.076.781.457.9 
P/CF ratio (eoy) x42.350.372.075.552.3 
Price / Book Value ratio x10.710.213.213.79.9 
Dividend payout %87.9112.2112.675.484.5 
Avg Mkt Cap Rs m212,038249,933288,643274,216203,280 
No. of employees `0005.04.74.64.7NA 
Total wages/salary Rs m3,6214,9304,4344,8305,234 
Avg. sales/employee Rs Th5,090.87,211.76,154.76,192.2NM 
Avg. wages/employee Rs Th719.31,058.6961.61,028.3NM 
Avg. net profit/employee Rs Th956.91,012.7815.8717.1NM 
GSK PHARMA INCOME DATA
Net Sales Rs m25,62733,58528,37929,08528,715 
Other income Rs m1,7701,9991,228731545 
Total revenues Rs m27,39735,58429,60729,81629,260 
Gross profit Rs m5,2826,2834,7834,1905,059 
Depreciation Rs m199254250263380 
Interest Rs m00032 
Profit before tax Rs m6,8538,0285,7614,6555,222 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m262-51923457178 
Tax Rs m2,2982,7932,0231,7441,892 
Profit after tax Rs m4,8174,7163,7613,3683,508 
Gross profit margin %20.618.716.914.417.6 
Effective tax rate %33.534.835.137.536.2 
Net profit margin %18.814.013.311.612.2 
GSK PHARMA BALANCE SHEET DATA
Current assets Rs m26,23925,87021,73716,74221,815 
Current liabilities Rs m8,8895,0025,7927,20215,999 
Net working cap to sales %67.762.156.232.820.3 
Current ratio x3.05.23.82.31.4 
Inventory Days Days4941685364 
Debtors Days Days1411162119 
Net fixed assets Rs m1,6202,4444,7778,63512,475 
Share capital Rs m847847847847847 
"Free" reserves Rs m19,03323,59420,98519,22219,726 
Net worth Rs m19,89724,44121,83220,06920,573 
Long term debt Rs m362616106 
Total assets Rs m31,29532,24430,54930,03839,475 
Interest coverage xNMNMNM1,552.72,612.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.81.00.91.00.7 
Return on assets %15.414.612.311.28.9 
Return on equity %24.219.317.216.817.1 
Return on capital %35.730.726.525.526.2 
Exports to sales %0.40.2000 
Imports to sales %12.312.914.900 
Exports (fob) Rs m9563400 
Imports (cif) Rs m3,1594,3344,23700 
Fx inflow Rs m625699519528564 
Fx outflow Rs m5,3807,6808,3207,1937,429 
Net fx Rs m-4,755-6,981-7,801-6,665-6,865 
GSK PHARMA CASH FLOW
From Operations Rs m 2,813 3,409 1,389 2,344 4,728 
From Investments Rs m 1,890 1,776 4,990 3,006 -1,042 
From Financial Activity Rs m -4,941 -4,970 -6,383 -5,108 -3,066 
Net Cashflow Rs m -239 215 -4 242 620 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 50.7%
Indian inst/Mut Fund 10.2%
FIIs 23.8%
ADR/GDR 0.0%
Free float 15.4%
Shareholders 102,036
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Dr. Annie Besant Road, Worli, Mumbai - 400 030
E-MAIL ajay.a.nadkarni@gsk.com WEB www.gsk-india.com
TELEPHONE (022) 2495 9415 FAX (022) 2498 1526
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Price Waterhouse & Co.
CHM: D. S. Parekh COMP SEC: A. A. Nadkarni (GM & Admin) YEAR OF INC: 1924 BSE CODE: 500660 FV (Rs): 10 DIV YIELD (%): 1.3

More Pharmaceuticals Company Fact Sheets:   FULFORD INDIA  DR. REDDYS LAB  ALKEM LABORATORIES  J.B.CHEMICALS  ELDER PHARMA  

Compare GSK PHARMA With:   FULFORD INDIA  DR. REDDYS LAB  ALKEM LABORATORIES  J.B.CHEMICALS  ELDER PHARMA  

Compare GSK PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Views on news

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0% (Quarterly Result Update)

Feb 5, 2019 | Updated on Feb 5, 2019

For the quarter ended December 2018, GSK PHARMA has posted a net profit of Rs 1 bn (up 26.0% YoY). Sales on the other hand came in at Rs 8 bn (up 17.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA - ACTAVIS COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS